Author: Chen, Zhang-Ren; Liu, Jing; Liao, Zhi-Guo; Zhou, Jian; Peng, Hong-Wei; Gong, Fei; Hu, Jin-Fang; Zhou, Ying
Title: COVID-19 and gastroenteric manifestations Cord-id: rtyiog6a Document date: 2021_7_6
ID: rtyiog6a
Snippet: Coronavirus disease 2019 (COVID-19), caused by the infection of a novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)], has become a pandemic. The infection has resulted in about one hundred million COVID-19 cases and millions of deaths. Although SARS-CoV-2 mainly spreads through the air and impairs the function of the respiratory system, it also attacks the gastrointestinal epithelial cells through the same receptor, angiotensin converting enzyme 2 receptor, which re
Document: Coronavirus disease 2019 (COVID-19), caused by the infection of a novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)], has become a pandemic. The infection has resulted in about one hundred million COVID-19 cases and millions of deaths. Although SARS-CoV-2 mainly spreads through the air and impairs the function of the respiratory system, it also attacks the gastrointestinal epithelial cells through the same receptor, angiotensin converting enzyme 2 receptor, which results in gastroenteric symptoms and potential fecal-oral transmission. Besides the infection of SARS-CoV-2, the treatments of COVID-19 also contribute to the gastroenteric manifestations due to the adverse drug reactions of anti-COVID-19 drugs. In this review, we update the clinical features, basic studies, and clinical practices of COVID-19-associated gastroenteric manifestations.
Search related documents:
Co phrase search for related documents- abdominal diarrhea and lopinavir ritonavir: 1, 2, 3
- abdominal diarrhea vomiting and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- abdominal diarrhea vomiting and lopinavir ritonavir: 1, 2
- abdominal diarrhea vomiting nausea and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- abdominal diarrhea vomiting nausea anorexia and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- abdominal diarrhea vomiting nausea anorexia include and acute sars cov respiratory syndrome coronavirus: 1, 2
- abdominal diarrhea vomiting nausea anorexia manifest and acute sars cov respiratory syndrome coronavirus: 1
- abdominal pain and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abdominal pain and adr adverse drug reaction: 1
- abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
- abdominal pain associate and acute sars cov respiratory syndrome coronavirus: 1
- accessible tool and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- acute sars cov respiratory syndrome coronavirus and adhesion receptor: 1, 2, 3
- acute sars cov respiratory syndrome coronavirus and adr adverse drug reaction: 1, 2
Co phrase search for related documents, hyperlinks ordered by date